Overview

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study in PD patients is designed to assess the affect food has on the absorption, distribution, metabolism and excretion of ropinirole (by dosing some patients in the fasted state and other patients following a high-fat breakfast), and to assess the difference in absorption, distribution, metabolism and excretion of ropinirole if patients are given three 4mg ropinirole tablets versus one 12mg tablet.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole